Literature DB >> 15565257

Audit of antibiotic use in a Brazilian University Hospital.

Laura Guimarães Fonseca1, Lucieni de Oliveira Conterno.   

Abstract

A cohort study was carried out at the Marilia Medical School Hospital. In the first phase the pattern of antibiotic use was evaluated. Antibiotics were prescribed for 55.4% of the patients; antibiotic combinations were used in 43%. Therapeutic use of antibiotics was considered inadequate in 27%. Respiratory and skin infections were the most frequently diagnosed. In up to 31% of the cases the treatment of respiratory infections was considered inadequate. The surgical use of antibiotic prophylaxis was evaluated in the second phase. Prophylaxis was indicated in 73.2% of the surgeries. The antibiotics most used for prophylaxis were first generation cephalosporins. In 78.9% of the surgeries, the antibiotic was correctly chosen. In 15.9% of the surgeries, the initial antibiotic administration was correctly timed. The use of antibiotics in the post-operative period was appropriate in 29.8% of the cases. The independent risk factors for surgical site infection (SSI), as determined by logistic regression analysis adjusted to class of wound risk, were the choice of antibiotic to be used prophylactically and the duration of antibiotic treatment in the post-operative period. Those who received appropriate prophylactic antibiotics had a lower rate of SSI than those who received innapropriated antibiotics [RR=0.49/95%; CI=0.25-0.90]. Patients who received prophylactic antibiotics correctly in the post-operative period had a lower risk of SSI than those who did not [RR=0.21/95%; CI=0.70-0.63]. The mean length of hospital stay was shorter among patients whose prophylactic treatment was correctly employed than among for which it was not [6.1 (+/-9.8) and 11.1 (+/-13.5) days, p=0.25].

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15565257     DOI: 10.1590/s1413-86702004000400002

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  7 in total

1.  Prophylactic antibiotics and wound infection.

Authors:  Abubaker Ibrahim Elbur; Yousif M A; Ahmed S A El-Sayed; Manar E Abdel-Rahman
Journal:  J Clin Diagn Res       Date:  2013-12-15

2.  Antibiotics use patterns for surgical prophylaxis site infection in different surgical wards of a teaching hospital in ahvaz, iran.

Authors:  Seyed Mohammad Alavi; Fatemeh Roozbeh; Farzaneh Behmanesh; Leila Alavi
Journal:  Jundishapur J Microbiol       Date:  2014-11-01       Impact factor: 0.747

3.  Benefits of WSES guidelines application for the management of intra-abdominal infections.

Authors:  Belinda De Simone; Federico Coccolini; Fausto Catena; Massimo Sartelli; Salomone Di Saverio; Rodolfo Catena; Antonio Tarasconi; Luca Ansaloni
Journal:  World J Emerg Surg       Date:  2015-03-18       Impact factor: 5.469

4.  An assessment of antibiotics prescribed at the secondary health-care level in the Kyrgyz Republic.

Authors:  Kambaralieva Baktygul; Bozgunchiev Marat; Zurdinov Ashirali; Md Harun-Or-rashid; Junichi Sakamoto
Journal:  Nagoya J Med Sci       Date:  2011-08       Impact factor: 1.131

5.  Antimicrobial agents' utilization and cost pattern in an Intensive Care Unit of a Teaching Hospital in South India.

Authors:  Nikhilesh Anand; I M Nagendra Nayak; M V Advaitha; Noble J Thaikattil; Kiran A Kantanavar; Sanjit Anand
Journal:  Indian J Crit Care Med       Date:  2016-05

6.  Surgical Antimicrobial Prophylaxis and Incidence of Surgical Site Infections at Ethiopian Tertiary-Care Teaching Hospital.

Authors:  Kerebih Alamrew; Tamrat Assefa Tadesse; Alfoalem Araba Abiye; Workineh Shibeshi
Journal:  Infect Dis (Auckl)       Date:  2019-11-27

7.  Changes in antimicrobial use prevalence in China: results from five point prevalence studies.

Authors:  Chunhui Li; Nan Ren; Ximao Wen; Pengcheng Zhou; Xun Huang; Ruie Gong; Yixin Lv; Li Feng; Hongman Wu; Zhenru Liu; Chenchao Fu; Xin Huang; Jie Li; Yuhua Chen; Cui Zeng; Shuangyan Zuo; Xinrui Xiong; Xiuhua Xu; Anhua Wu
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.